A structured assessment process can determine compliance to lifecycle process-validation requirements for biopharmaceuticals.
Amol Galande
Advertisement
Amol Galande is senior manager of the process development laboratory at Lupin Pharmaceuticals.
Articles by Amol Galande
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
2
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
3
Implementing Automation and Flexible Design for Allogeneic Manufacturing
4
Biocapacitance as a PAT Tool: Real-Time Biomass Monitoring for Upstream Bioprocessing
5
